On May 16, 2019, the U.S. Food and Drug Administration (FDA) issued a Warning Letter to KratomNC, highlighting significant concerns regarding the marketing and safety of […]
On May 18, 2018, the U.S. Food and Drug Administration (FDA) issued a warning letter to Kratom Spot, a retailer of kratom products, addressing significant regulatory […]
On June 30, 2022, the U.S. Food and Drug Administration (FDA) issued a warning letter to the Kratom Exchange, addressing significant concerns regarding the marketing practices […]
On June 30, 2022, the U.S. Food and Drug Administration (FDA) issued a warning letter to Klarity Kratom, a manufacturer of kratom products, highlighting significant regulatory […]
This warning letter addresses regulatory violations identified at Herbsens Botanicals during an FDA inspection. The inspection revealed significant issues regarding the labeling and marketing practices of […]
This study explored the chemical composition of kratom leaves from Malaysia and investigated the effects of certain alkaloids found in kratom on opioid receptors. The researchers […]
The study was conducted in Tambon Namphu, a rural region in southern Thailand where kratom has been used traditionally. Researchers used surveys, interviews, and focus groups […]
Kratom is a plant from Southeast Asia that some people use to relieve pain and reduce opioid withdrawal symptoms. The article looks at the different chemicals […]